by Hiroto S. Watanabe (Editor)

This book analyzes advances in cancer research. Chapter 1 will highlight the main features regarding the most outstanding contributions around stimuli-responsive lipid-based nanovesicles and the recent advances in their biomedical applications in cancer. Chapter 2 will more closely discuss the involvement of the AGR protein family in EMT and cancer, with a special focus on AGR2. Chapter 3 covers liquid biopsies, immunotherapy, liquid biopsies, and combinational therapies. Chapter 4 discusses data that will allow revealing additional mechanisms of tumor growth and will be the basis for improving existing antitumor treatment regimens in patients with triple receptor-negative breast cancer, which is characterized by a high degree of malignancy. Chapter 5 reviews the EMT process of cervical cancer cells. Chapter 6 discusses youth SHS exposure and how it is a major public health issue worldwide. Chapter 7 analyzes a specific study dealing with breast biopsy and mammograms of benign and malignant lesions. Chapter 8 reviews the development of Pharmacogenomics studies. Chapter 9 provides an overview of the principles and applications of statistical risk stratification in surgery, highlighting its significance in optimizing patient care and enhancing surgical outcomes.